iRhythm Technologies (IRTC)
(Real Time Quote from BATS)
$111.30 USD
-0.82 (-0.73%)
Updated Apr 19, 2024 02:14 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
iRhythm Technologies (IRTC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$130.90 | $165.00 | $94.00 | 16.75% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for iRhythm Technologies comes to $130.90. The forecasts range from a low of $94.00 to a high of $165.00. The average price target represents an increase of 16.75% from the last closing price of $112.12.
Analyst Price Targets (10)
Broker Rating
iRhythm Technologies currently has an average brokerage recommendation (ABR) of 1.09 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.09 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 90.91% and 9.09% of all recommendations. A month ago, Strong Buy made up 90.91%, while Buy represented 9.09%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 9 |
Buy | 1 | 1 | 1 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.09 | 1.09 | 1.09 | 1.09 | 1.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/27/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
2/23/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
2/23/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
1/7/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
12/13/2023 | Truist Securities | Richard Newitter | Strong Buy | Strong Buy |
7/19/2023 | Robert W. Baird & Co. | David Rescott | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.09 |
ABR (Last week) | 1.09 |
# of Recs in ABR | 11 |
Average Target Price | $130.90 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 149 of 252 |
Current Quarter EPS Est: | -0.99 |